Immunodiagnostic Systems Holdings PLC (LSE:IDH) - Share price - Overview

Stock Report

Immunodiagnostic Systems Holdings PLC IDH

Last Price
GBX300.00

Day Change
0.00|0.00%

As of 21/07/2017
11:39:11 BST | GBX
Minimum 15 Minutes Delay.

Last Close300.00p
Day Range303.00 - 303.00
Mkt Cap88.24Mil
52-Wk Range142.00 - 320.00
Yield %0.40
ISINGB00B01YZ052
Volume3,332
P/E19.64
P/S2.20
P/CF10.36

Share Price

Total Returns 21/07/2017

 Chg (%)  
More ...
Immunodiagnostic Systems Holdings PLC3.93 
FTSE 100 TR GBP0.14
 
Financials
201520162017
More ...
Income Statement
Turnover45.3638.3140.04
Operating Profit3.27-36.801.65
Net Profit2.35-32.173.01
Reported EPS8.00-109.7010.20
Balance Sheet
Current Assets40.5543.1848.94
Non Current Assets56.5519.1619.79
Total Assets97.1062.3468.74
Current Liabilities7.196.558.22
Total Liabilities16.6910.7412.00
Total Equity80.4151.6056.73
Cash Flow
Operating Cash Flow8.948.097.64
Net Change in Cash-2.442.384.27
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
2018-9.10-40.4332.97-0.82--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/06/2017PurchasePaul Martin290.002,1006,090.00
22/03/2017PurchasePaul Martin277.003,0008,310.00
20/01/2017PurchaseMr. Till Campe249.001,8004,482.00
11/01/2017PurchaseMr. Till Campe245.001,5003,675.00

Company Profile

Immunodiagnostic Systems Holdings PLC is engaged in the manufacturing and distributing medical diagnostic products. It operates in three business units: automated IVD business, manual IVD business and Licensing and Technology.

Sector

Medical Devices

Market Position

936 of 1845 Companies

Index

FTSE AIM All Share

Outlook

(21/06/2017) ch - "...I am looking forward to more positive developments in the next few years"

Next Event 27/07/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)0.0019.6516.42
Div Yld (E)0.001.664.08
PEG (E)0.000.671.03
ROCE5.3619.5410.96
Op Mrgn6.294.884.34
EPS Grwth0.0068.0130.04
Dividends
PreviousLatest
More ...
Record Date22/07/1621/07/17
Ex-Div21/07/1620/07/17
Paid19/08/1618/08/17
Amnt1.204.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr Burkhard Wittek
Chief Financial Officer & Company SecretPaul Martin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.